Objetivo
The projects objective is the development of a manufacturing process to be patented to produce anew, stable pharmaceutical extract by either inhabitation of enzymatic degradation of Glucosinolates to Isythiocyanates during the chopping up of the plant material or by stabilizing the isothiocyanates in the plant extract. The project will cover one of the aria type drugs America rustic Ana, Nasturtiumofficinalis or Tropaelum magus, which are effective against cold diseases. The resulting extract will be tested doxologically and pharmaceutically and a medicinal product in an appropriate pharmaceutical form will be developed. A plan for clinical trials of the medicinal product will schedule. Moorages of this kind are not available on the market. The She's expected to open a new market for themselves and others, as the process, once validated, will be transferable to other phytochemicalproducts.
Ámbito científico
CORDIS clasifica los proyectos con EuroSciVoc, una taxonomía plurilingüe de ámbitos científicos, mediante un proceso semiautomático basado en técnicas de procesamiento del lenguaje natural.
CORDIS clasifica los proyectos con EuroSciVoc, una taxonomía plurilingüe de ámbitos científicos, mediante un proceso semiautomático basado en técnicas de procesamiento del lenguaje natural.
Convocatoria de propuestas
Data not availableRégimen de financiación
EAW - Exploratory awardsCoordinador
73240 Wendingen
Alemania